ストックスクリーナーアプリを入手
53.94
0.50%
-0.27
アフターアワーズ：
53.97
0.03
+0.06%
Bristol Myers Squibb Co (BMY) 最新ニュース
Looking Into Bristol-Myers Squibb Co's Recent Short Interest - Benzinga
Ex-Dividend Reminder: Encompass Health, Bristol Myers Squibb and Federal Realty Investment Trust - Nasdaq
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
Bristol-Myers Squibb stock edges higher as Wall Street drifts into year-end — what’s next for BMY - ts2.tech
Goldman Sachs Raises Bristol-Myers (BMY) Target, Keeps Neutral Rating - Finviz
BMY vs AMGN: Which Biotech Stock Is More Resilient Now? - Finviz
Is Bristol Myers Squibb a buy, sell, or hold in 2026? - MSN
Is Bristol Myers Squibb a Buy, Sell, or Hold in 2026? - The Motley Fool
Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever - Finviz
Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever - The Motley Fool
Bristol-Myers Squibb Stock Finds a Floor as Wall Street Bets on a Late-Cycle Rebound - AD HOC NEWS
Diversified Trust Co Has $4.56 Million Stake in Bristol Myers Squibb Company $BMY - MarketBeat
Inside Bristol-Myers Squibb: How a Quiet Pharma Giant Is Re?Architecting the Future of Cancer and Im - AD HOC NEWS
What does Wall Street think about Bristol-Myers Squibb Company (BMY)? - MSN
What Does Wall Street Think About Bristol-Myers Squibb Company (BMY)? - Finviz
10 Best Affordable Healthcare Stocks to Buy Now - Insider Monkey
Bristol-Myers Squibb Stock: Defensive Pharma Giant Tests Investor Patience As Wall Street Turns Sele - AD HOC NEWS
Bristol Myers Squibb stock slips today as year-end trading thins and dividend date nears - ts2.tech
Bristol Myers Squibb (BMY) Stock: Weekend News, Analyst Targets, Dividend Update, and What to Watch Before Monday’s Open - ts2.tech
Bristol-Myers Squibb Charts a New Strategic Course with U.S. Government Pact - AD HOC NEWS
Bristol-Myers Squibb (BMY) Stock: Weekend Market Close, Fresh Institutional Filings, and What to Watch Before Monday’s Open - ts2.tech
Meyer Handelman Co. Sells 52,438 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Trust Co. of Toledo NA OH Increases Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts - ts2.tech
Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever - Finviz
Bristol-Myers Squibb: Contrarian Buy For Dividend Hunters, Despite Mounting Growth Headwinds - Seeking Alpha
Bristol Myers Squibb: A Pharma Giant Trading Like Growth Is OverIt's Not - Seeking Alpha
Bristol Myers lines up many launches for India with 'AI' speed - The Economic Times
Bristol-Myers (BMY) Offers Eliquis Free to Medicaid Patients Under New Pricing Pact - Finviz
Is Bristol Myers Squibb (BMY) Still Undervalued After Its Recent Share Price Rebound? - Yahoo Finance UK
Bristol-Myers Squibb (BMY) Stock News Today: Supreme Court Bid, Drug-Pricing Deals, Dividend Boost, and 2026 Forecasts (Dec. 23, 2025) - ts2.tech
J&J, Bristol Myers Ask High Court to Review US Drug Price Cuts - Bloomberg Law News
Bristol-Myers Squibb Surges Into Year-End: Why BMY Still Looks Undervalued (NYSE:BMY) - Seeking Alpha
Bristol-Myers Squibb: Still Undervalued And Generating 4.65% Dividend Yield - Seeking Alpha
Bristol-Myers Squibb stock holds Buy rating at Guggenheim amid oHCM competition - Investing.com India
3 Top Value Stocks to Buy and Hold for 2026 - Morningstar
Harbour Biomed closes busy year with $1B+ BMS deal - BioWorld MedTech
Bristol-Myers Squibb (BMY) Stock After Hours Today, Dec. 22, 2025: What to Know Before the Market Opens Tuesday - ts2.tech
Exchange Traded Concepts LLC Purchases 83,214 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Sold by First Bank & Trust - MarketBeat
Bristol-Myers Squibb Secures Regulatory Truce with Landmark U.S. Pricing Deal - AD HOC NEWS
Cytokinetics set to battle Bristol Myers as FDA approves heart drug - BioPharma Dive
BofA Upgrades Bristol-Myers Squibb (BMY) Stock to Buy from Neutral - Finviz
FDA Approves Bristol-Myers Squibb's Breyanzi as First-Ever CAR T Therapy for Rare Marginal Zone Lymphoma - Finviz
FDA Approves Bristol-Myers Squibb’s Breyanzi as First-Ever CAR T Therapy for Rare Marginal Zone Lymphoma - Insider Monkey
Flputnam Investment Management Co. Purchases 64,133 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
How Bristol Myers Squibb Company Equity Right stock compares to industry benchmarksEarnings Performance Report & Verified Swing Trading Watchlist - Улправда
Leerink Partners Sticks to Its Buy Rating for Bristol-Myers Squibb (BMY) - The Globe and Mail
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal - Benzinga
US FDA approves Cytokinetics' heart disease drug - Reuters
Nine biopharmas agree to most-favoured nation drug pricing in the US - FirstWord Pharma
Bristol Myers Squibb (BMY) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Cytokinetics Takes On Bristol With Newly Approved Heart Drug - Bloomberg.com
WATCH: Trump announces 9 pharmaceutical companies will lower drug prices - PBS
Bristol Myers Squibb to provide Eliquis free to Medicaid starting 2026 By Investing.com - Investing.com Nigeria
Bristol Myers Squibb to provide Eliquis free to Medicaid starting 2026 - Investing.com
9 pharma giants reach US drug price deals with Trump administration - Fierce Pharma
Bristol Myers Squibb (BMY) Joins New Deal to Lower Drug Prices i - GuruFocus
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts - Benzinga
9 more drugmakers agree to Trump’s policy to lower some prices - The Hill
0.57%
大文字化:
|
ボリューム (24 時間):